PHIA Koninklijke Philips N.V.

Philips and University Hospital Brandenburg an der Havel sign 10-year partnership to advance patient care

Philips and University Hospital Brandenburg an der Havel sign 10-year partnership to advance patient care

January 28, 2022

  • Major German University Hospital secures long-term access to the latest health technology through renewal of diagnostic and image-guided therapy solutions
  • Philips to deliver new and upgraded hybrid operating room and interventional suites
  • Agreement includes training and education for hospital’s clinicians and medical technologists

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the University Hospital Brandenburg an der Havel (Brandenburg, Germany) have signed a 10-year strategic partnership to renew and expand the hospital’s diagnostic and therapy options through the delivery of advanced technology solutions. The approximately EUR 18 million agreement includes the supply of diagnostic imaging solutions including ultrasound, MR and mobile X-ray, as well as image-guided therapy suites and patient monitoring solutions. The long-term cooperation will provide University Hospital Brandenburg an der Havel with optimum flexibility and a needs-based approach to technology selection and financing.

"We have decided to partner with Philips in order to ensure high-quality, economical medical care for the population of our region into the future," said Gabriele Wolter, Managing Director of University Hospital Brandenburg an der Havel. “Our joint activities will go well beyond device procurement and financing. There will be a uniform operating philosophy across devices and departments for renewal of our equipment inventory. In this way, we can speed up processes, minimize operating errors, and make its use easier throughout the clinic.”

With around 500 beds, provides specialist care both locally and nationally for around 26,000 inpatients and 48,000 ambulatory patients in 15 specialized clinics. With medical excellence, innovative therapies and interdisciplinary teams, more than 2,000 employees work toward a common goal: ensuring first-class treatment quality by linking teaching, research and patient care.

Advanced diagnostic and therapy options, together with a modern standardized equipment inventory, are an important part of the hospital’s development for the future. A significant strategic element of the agreement with Philips is enhancement of the hospital’s vascular and cardiology specialist services. This includes the upgrading of two existing interventional suites for cardiac and vascular procedures and installation of a new hybrid operating room equipped with for minimally-invasive interventions. Minimally invasive techniques offer significant benefits for healthcare systems and patients, including reduced patient trauma (less patient risk), shorter recovery times and hospital stays (faster patient throughput), and lower health care costs.

"The aim of our cooperation is to take a holistic approach to the design and organization of healthcare along the full treatment pathways in the hospital, with our top priorities being improving outcomes, enhancing the patient and staff experience, and reducing the cost of care," said Heiko Borwieck, Health Systems Sales Leader, Philips Germany.

Well-trained medical and nursing staff are an important part of comprehensive patient care. Philips’ ICARUS learning academy for medical and technical staff will be integrated into the hospital’s existing training and education program as part of the cooperation. Combining digital and face-to-face teaching methods, the platform will allow the hospital’s radiology team to be trained individually or in groups, independent of their location. The aim is to meet the daily challenges of the radiology workplace through the training of all employees so that the hospital can deliver a high-quality standard of care.

For further information, please contact:

Mark Groves

Philips Global Press Office

Tel:

Email:

Annette Halstrick

PR Manager Health Systems

Philips GmbH DACH

Phone: 29

Email:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachment



EN
28/01/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

Marc Hesselink ... (+2)
  • Marc Hesselink
  • CFA

Philips/Execution is key/HOLD

Philips reported a better-than-expected 4Q25 update and a supportive CMD message. We increase our estimates, raise our target price from €23 to €26 and reiterate our Hold rating. Philips appears positioned to continue progressing operationally, but we believe consistent delivery will be required before we see meaningful outperformance versus the sector. Valuation at 15x adj EPS 2027F is in line with peers.

 PRESS RELEASE

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for spe...

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments March 4, 2026 CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging a...

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch